Iruplinalkib

DB17494InvestigationalSmall molecule

Iruplinalkib: Overview.

Mechanism: Pharmacologically active on ALK tyrosine kinase receptor and Proto-oncogene tyrosine-protein kinase ROS
Curator reviewed
Code names: WX-0593

Resolves to

Compound

Targets

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

11Clinical trialsPhase, status and sponsor resolved per trial

12+ReferencesStructured and connected to the statements they support

Which drugs share a target with Iruplinalkib, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.